Manufacturer discounts on the price of branded drugs provided to Medicare Part D beneficiaries in the coverage gap will increase from 50% to 70% beginning in 2019 under federal budget legislation under consideration in the Senate.
Development of a Senate plan that would extend the budget at least through mid-March 2019. Once the Senate has passed...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?